Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. Ordinary Shares（DMAA）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · DMAA · 截至 Jun 8, 2026
关键指标
探索 Drugs Made In America Acquisition Corp. Ordinary Shares 数据
dmaa stock data · financials财务快照
完整财报竞争对手与同行
dmaa competitorsDMAA
ALF
LOKV
MLAC
OYSE
RTAC股票表现
完整历史关于 Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. Ordinary Shares Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stoc…
what is drugs made in america acquisition corp. ordinary shares · dmaa stock overview · drugs made in america acquisition corp. ordinary shares company profile · who is drugs made in america acquisition corp. ordinary shares ceo · dmaa NASDAQ · drugs made in america acquisition corp. ordinary shares headquarters · drugs made in america acquisition corp. ordinary shares business segments
关于股票概览与关键数据
Drugs Made In America Acquisition Corp. Ordinary Shares（DMAA）是 Shell Companies 行业的 Financial Services 类公司，于 Jan 27, 2025 在 NASDAQ 上市。截至最近交易日，DMAA 股价为 $10.61，市值约为 $357.7M。过去12个月累计回报 +4.43%，年初至今回报 +2.31%。
2025 财年 Drugs Made In America Acquisition Corp. Ordinary Shares 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Drugs Made In America Acquisition Corp. Ordinary Shares（DMAA）股价为 $10.61，在 NASDAQ 上市，52周区间为 $10.15 – $10.61。